Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, announced the appointment of Carlos Pena as Chief Financial Officer. Pena brings over a decade of experience in accounting, financial management, and audit support across industries including insurance, technology, and professional services. His appointment comes as the company advances its strategic transition into AI-enabled healthcare and digital health services for emerging markets, with an initial focus on Latin America.
Pena began his career in external audit with Crowe Horwath International, where he supported audit procedures, internal control evaluations, and financial reporting processes. He subsequently held roles with Banesco Seguros, Vivir Seguros, and Netser Venezuela, handling financial analysis, reconciliations, and regulatory compliance. More recently, he served as Supervisor of Administration and Finance in the aviation sector, overseeing financial operations, budgeting, internal controls, and audit coordination. Additionally, Pena has worked as an independent accountant, assisting businesses with financial reporting, tax filings, payroll administration, and compliance with local regulatory requirements. He holds a degree in Public Accounting from Universidad Alejandro de Humboldt in Caracas, Venezuela.
As CFO, Pena is expected to support the company’s financial reporting functions, accounting infrastructure, and internal control processes as it pursues its strategic initiatives in artificial intelligence-driven healthcare. Dr. Kevin Rodan Levy, CEO of Catalyst Crew Technologies, stated: “Carlos brings strong hands-on financial and operational experience that we believe will be valuable as we continue building our financial infrastructure and supporting our growth initiatives in Latin America.”
Catalyst Crew Technologies is building an integrated healthcare technology platform through technology development, strategic partnerships, and targeted acquisitions. The company focuses on telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination in underserved markets. The company is a development-stage enterprise and has not yet generated revenues from its newly announced business direction, as noted in its forward-looking statements and risk disclosures.
For more information, visit https://catalystcrewai.com or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
